Jamila Hamdani

Jamila Hamdani is a researcher affiliated with the University of Liège, focusing on clinical pharmacology and drug optimization in infectious diseases. Her work spans vaccine safety, pharmacokinetic modeling, and public health studies.

• Key research areas: Pharmacokinetics, vaccine safety, and prescription drug misuse
• Collaborated on 4 peer-reviewed publications (2020-2023)

Her recent studies address critical challenges in hydroxychloroquine dosing for COVID-19 patients and safety evaluation of vaccines in vulnerable populations. She contributes to public health through analyses of prescription stimulant misuse among university students.

Research trends include:

• Model-informed drug development
• Dose optimization strategies
• Pharmacovigilance during pandemics
• Clinical uncertainty analysis